Chemicals · Founded 2004 · www.fineotex.com · BSE 533333 · NSE FINEOTEX CH · ISIN INE045J01034
No Notes Added Yet
Business
Fineotex Chemical Ltd. (FCL) is an Indian specialty chemical manufacturer. The company's core business involves producing a wide range of chemicals primarily for the textile industry (Textile Auxiliaries) and various other industrial applications, including water treatment, drilling fluids, and home care. FCL operates on a business-to-business (B2B) model, selling its specialty chemical formulations to industrial clients who use them as critical inputs in their manufacturing processes or services. The company makes money by developing, producing, and selling these value-added chemical products, often customized or technically sophisticated, to help clients improve product quality, efficiency, or sustainability.
Revenue Mix
FCL's primary revenue streams are derived from:
Textile Auxiliaries: This segment includes a comprehensive range of chemicals used in various stages of textile processing such as pre-treatment, dyeing, printing, and finishing. These chemicals enhance fabric properties, improve processing efficiency, and ensure product quality. This is historically FCL's largest segment.
Ancillary Chemicals: This segment includes chemicals for diverse applications like water treatment, drilling fluid chemicals for the oil & gas industry, cleaning & hygiene products, and construction chemicals. While smaller than textile auxiliaries, this segment represents FCL's diversification efforts.
Industry
FCL operates within the Indian specialty chemicals industry, which is characterized by a fragmented market, technical expertise requirements, and often custom-solution offerings. The industry serves a wide array of end-user sectors. FCL positions itself as a niche player focusing on specialty and performance chemicals rather than commodity chemicals. It competes with both domestic and international chemical manufacturers, often differentiated by product quality, technical support, customization capabilities, and pricing. Its long-standing presence in the textile chemical space provides it with established relationships and technical know-how.
MOAT
FCL's competitive advantages primarily stem from:
Technical Expertise & R&D: Development of specialized formulations and customized solutions for specific client needs. This involves ongoing investment in R&D to innovate and adapt to changing industry demands and regulations.
Client Relationships & Service: Long-standing relationships with customers in the textile industry built on consistent product quality and technical support. Switching costs for clients can be moderate due to process integration and product-specific formulations.
Diversification: While textiles are a core segment, diversification into other specialty chemical areas like water treatment and drilling fluids reduces over-reliance on a single industry.
Growth Drivers
Key factors that can drive FCL's growth over the next 3-5 years include:
Growth in End-User Industries: Increased demand from the textile sector (both domestic and export), water treatment, and oil & gas industries.
Diversification into New Niches: Expansion into new specialty chemical applications like home care, industrial cleaning, or other performance-enhancing chemicals.
Export Opportunities: Leveraging its product portfolio and technical expertise to capture market share in international markets.
Focus on Sustainable/Green Chemistry: Developing and offering environmentally friendly chemical solutions, driven by increasing regulatory and consumer demand for sustainability.
Capacity Expansion: Strategic investments in manufacturing capacity to meet growing demand.
Risks
Raw Material Price Volatility: FCL's profitability is exposed to fluctuations in crude oil prices and other chemical intermediates, which are key raw materials.
Intense Competition: The specialty chemicals market is competitive, with numerous domestic and international players vying for market share, which can pressure pricing and margins.
Regulatory Changes: Stricter environmental regulations, safety standards, or product specific bans could impact manufacturing processes or product portfolios.
Economic Downturns: A slowdown in end-user industries (e.g., textiles, manufacturing) can directly impact demand for FCL's products.
Foreign Exchange Fluctuations: For imports of raw materials or exports of finished goods, currency volatility can impact costs and revenues.
Management & Ownership
Fineotex Chemical Ltd. is an Indian promoter-led company. The promoters and their families typically hold a significant stake, demonstrating strong alignment with the company's long-term interests. The management team likely comprises professionals with experience in the chemical industry, responsible for operational execution and strategic direction. The ownership structure generally includes the promoter group, institutional investors, and public shareholders.
Outlook
Fineotex Chemical Ltd. operates in a growing and vital specialty chemicals sector. The company's focus on technical expertise, diversification, and established customer relationships in the textile industry provides a stable base. Potential growth drivers like increased demand from end-user industries, diversification into new segments, and export opportunities could fuel future expansion. However, the company faces inherent risks such as raw material price volatility, intense competition, and regulatory changes, which could impact profitability. Its ability to innovate, manage costs, and navigate these industry dynamics will be crucial for sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 138 | 153 | 142 | 146 | 126 | 120 | 137 | 138 | 184 | 314 |
| Other Income | 5 | 4 | 5 | 7 | 5 | 8 | 9 | 8 | 7 | 9 |
| Total Income | 143 | 157 | 147 | 153 | 131 | 127 | 146 | 145 | 190 | 323 |
| Total Expenditure | 98 | 115 | 107 | 109 | 92 | 98 | 112 | 107 | 149 | 270 |
| Operating Profit | 45 | 42 | 40 | 43 | 39 | 29 | 34 | 39 | 42 | 53 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 44 | 40 | 38 | 41 | 36 | 26 | 31 | 35 | 38 | 48 |
| Provision for Tax | 11 | 10 | 8 | 9 | 9 | 6 | 6 | 9 | 8 | 4 |
| Profit After Tax | 33 | 30 | 29 | 32 | 28 | 20 | 25 | 26 | 30 | 44 |
| Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -4 | -12 |
| Profit After Adjustments | 33 | 30 | 29 | 32 | 28 | 20 | 25 | 26 | 26 | 32 |
| Adjusted Earnings Per Share | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 102 | 110 | 127 | 141 | 182 | 196 | 219 | 368 | 517 | 569 | 533 | 773 |
| Other Income | 5 | 2 | 10 | 5 | 1 | 2 | 17 | 6 | 7 | 17 | 24 | 33 |
| Total Income | 107 | 112 | 137 | 146 | 183 | 198 | 236 | 374 | 524 | 586 | 558 | 804 |
| Total Expenditure | 85 | 82 | 98 | 111 | 148 | 162 | 178 | 297 | 404 | 421 | 406 | 638 |
| Operating Profit | 21 | 30 | 39 | 35 | 35 | 36 | 58 | 77 | 120 | 165 | 152 | 168 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 13 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 20 | 29 | 38 | 34 | 34 | 22 | 56 | 73 | 115 | 158 | 141 | 152 |
| Provision for Tax | 6 | 9 | 9 | 10 | 9 | 8 | 11 | 16 | 25 | 37 | 32 | 27 |
| Profit After Tax | 15 | 20 | 29 | 24 | 24 | 14 | 45 | 57 | 90 | 121 | 109 | 125 |
| Adjustments | -2 | -3 | -3 | -1 | -2 | -1 | -2 | -2 | -1 | -1 | -1 | -16 |
| Profit After Adjustments | 13 | 17 | 26 | 23 | 23 | 13 | 43 | 55 | 88 | 120 | 108 | 109 |
| Adjusted Earnings Per Share | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.4 | 0.5 | 0.8 | 1.1 | 0.9 | 0.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -6% | 13% | 22% | 18% |
| Operating Profit CAGR | -8% | 25% | 33% | 22% |
| PAT CAGR | -10% | 24% | 51% | 22% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 56% | 8% | 35% | 31% |
| ROE Average | 19% | 26% | 25% | 22% |
| ROCE Average | 24% | 34% | 32% | 29% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 76 | 91 | 112 | 136 | 159 | 170 | 209 | 262 | 349 | 447 | 731 |
| Minority's Interest | 5 | 5 | 7 | 6 | 6 | 6 | 7 | 7 | 7 | 6 | 8 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | -0 | 0 | 1 | 0 | 1 | 2 | 3 | 5 | 9 |
| Total Current Liabilities | 19 | 18 | 20 | 19 | 29 | 31 | 50 | 68 | 64 | 89 | 67 |
| Total Liabilities | 100 | 114 | 140 | 161 | 195 | 207 | 267 | 339 | 423 | 548 | 815 |
| Fixed Assets | 18 | 19 | 23 | 25 | 32 | 37 | 56 | 80 | 95 | 137 | 179 |
| Other Non-Current Assets | 37 | 45 | 58 | 63 | 54 | 55 | 46 | 28 | 104 | 125 | 375 |
| Total Current Assets | 45 | 50 | 59 | 65 | 101 | 108 | 158 | 225 | 217 | 279 | 254 |
| Total Assets | 100 | 114 | 140 | 161 | 195 | 207 | 267 | 339 | 423 | 548 | 815 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 12 | 9 | 9 | 7 | 4 | 17 | 23 | 21 | 29 | 30 | 56 |
| Cash Flow from Operating Activities | 14 | 14 | 19 | 6 | 12 | 28 | 9 | 13 | 107 | 97 | 69 |
| Cash Flow from Investing Activities | -12 | -10 | -11 | -9 | 4 | -19 | -7 | -1 | -102 | -46 | -273 |
| Cash Flow from Financing Activities | -3 | -1 | -6 | -4 | -3 | -4 | -4 | -6 | -6 | -24 | 176 |
| Net Cash Inflow / Outflow | -1 | 2 | 2 | -7 | 13 | 5 | -2 | 7 | -1 | 27 | -27 |
| Closing Cash & Cash Equivalent | 9 | 9 | 8 | 4 | 17 | 23 | 21 | 29 | 30 | 56 | 29 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.12 | 0.15 | 0.23 | 0.2 | 0.2 | 0.12 | 0.38 | 0.5 | 0.8 | 1.08 | 0.94 |
| CEPS(Rs) | 0.13 | 0.18 | 0.27 | 0.22 | 0.23 | 0.14 | 0.42 | 0.54 | 0.85 | 1.15 | 1.03 |
| DPS(Rs) | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 | 0.04 | 0.08 | 0.16 | 0.08 |
| Book NAV/Share(Rs) | 0.68 | 0.81 | 1.01 | 1.22 | 1.43 | 1.52 | 1.89 | 2.37 | 3.15 | 4.03 | 6.38 |
| Core EBITDA Margin(%) | 15.22 | 23.69 | 21.94 | 20.97 | 18.89 | 17.72 | 18.57 | 19.34 | 21.78 | 26.08 | 23.85 |
| EBIT Margin(%) | 18.94 | 25.04 | 28.72 | 24.13 | 18.9 | 11.51 | 25.9 | 20.15 | 22.36 | 27.93 | 26.68 |
| Pre Tax Margin(%) | 18.64 | 24.71 | 28.43 | 23.73 | 18.45 | 11.19 | 25.57 | 19.9 | 22.21 | 27.69 | 26.48 |
| PAT Margin (%) | 13.47 | 16.88 | 21.63 | 16.77 | 13.35 | 7.29 | 20.39 | 15.45 | 17.32 | 21.27 | 20.48 |
| Cash Profit Margin (%) | 13.93 | 17.36 | 22.1 | 17.22 | 13.9 | 7.88 | 21.07 | 16.13 | 18.15 | 22.33 | 22.21 |
| ROA(%) | 15.55 | 18.42 | 22.94 | 15.95 | 13.68 | 7.12 | 18.79 | 18.76 | 23.5 | 24.93 | 16.03 |
| ROE(%) | 20.69 | 23.52 | 28.53 | 19.31 | 16.52 | 8.71 | 23.51 | 24.13 | 29.34 | 30.45 | 18.56 |
| ROCE(%) | 28.02 | 33.92 | 37.14 | 27.16 | 22.86 | 13.54 | 29.35 | 31.12 | 37.3 | 39.32 | 24.04 |
| Receivable days | 74.47 | 74.51 | 74.2 | 73 | 77.12 | 95.72 | 114.02 | 95.93 | 74.94 | 77.05 | 87.15 |
| Inventory Days | 36.81 | 34.19 | 33.42 | 43.71 | 46.22 | 42.92 | 41.63 | 43.79 | 37.73 | 31.24 | 39.21 |
| Payable days | 80.92 | 85.25 | 75.69 | 60.61 | 53.07 | 69.55 | 82.68 | 78.44 | 59.42 | 65.49 | 75.66 |
| PER(x) | 19.39 | 21.32 | 14.75 | 28.66 | 20.26 | 12.6 | 17.11 | 36.15 | 29.21 | 34.06 | 24.33 |
| Price/Book(x) | 3.28 | 3.98 | 3.38 | 4.79 | 2.87 | 0.97 | 3.48 | 7.61 | 7.4 | 9.14 | 3.6 |
| Dividend Yield(%) | 0.45 | 0.62 | 0.29 | 0.34 | 0.24 | 0.34 | 0.46 | 0.22 | 0.34 | 0.43 | 0.35 |
| EV/Net Sales(x) | 2.37 | 3.25 | 2.9 | 4.59 | 2.43 | 0.76 | 3.2 | 5.32 | 4.89 | 7.11 | 4.86 |
| EV/Core EBITDA(x) | 11.52 | 11.97 | 9.4 | 18.42 | 12.57 | 4.12 | 12.03 | 25.53 | 21.08 | 24.54 | 17.1 |
| Net Sales Growth(%) | 17.66 | 7.78 | 15.57 | 11.09 | 29.2 | 7.68 | 11.29 | 68.52 | 40.4 | 10.05 | -6.26 |
| EBIT Growth(%) | 77.45 | 42.5 | 31.99 | -10.65 | -0.08 | -34.45 | 150.48 | 31.14 | 55.8 | 37.43 | -10.44 |
| PAT Growth(%) | 86.73 | 35.07 | 47.45 | -17.55 | 1.53 | -41.19 | 211.37 | 27.68 | 57.42 | 35.14 | -9.76 |
| EPS Growth(%) | 98.65 | 31.95 | 52.79 | -12.05 | -0.76 | -41.94 | 227.3 | 29.56 | 60.06 | 35.64 | -12.69 |
| Debt/Equity(x) | 0.02 | 0.03 | 0.01 | 0.04 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0 |
| Current Ratio(x) | 2.37 | 2.74 | 2.92 | 3.5 | 3.43 | 3.45 | 3.19 | 3.3 | 3.39 | 3.12 | 3.78 |
| Quick Ratio(x) | 1.82 | 2.1 | 2.27 | 2.36 | 2.58 | 2.78 | 2.61 | 2.42 | 2.65 | 2.56 | 2.82 |
| Interest Cover(x) | 62.81 | 75.28 | 98.77 | 60.58 | 41.37 | 35.85 | 78.16 | 80.38 | 140.91 | 119.35 | 133.14 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0 | 0.01 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.03 | 65.03 | 64.46 | 62.88 | 62.86 | 62.88 | 62.88 | 62.88 | 62.57 | 62.3 |
| FII | 0.81 | 1.45 | 0.93 | 3.28 | 3.36 | 2.84 | 2.51 | 2.34 | 2.52 | 2.92 |
| DII | 3.69 | 3.7 | 3.68 | 3.63 | 3.61 | 3.71 | 3.17 | 1.63 | 1.28 | 1.27 |
| Public | 30.46 | 29.82 | 30.94 | 30.21 | 30.17 | 30.58 | 31.44 | 33.14 | 33.63 | 33.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 72.55 | 72.55 |
| FII | 0.09 | 0.16 | 0.1 | 0.38 | 0.38 | 0.32 | 0.29 | 0.27 | 2.93 | 3.4 |
| DII | 0.41 | 0.41 | 0.41 | 0.42 | 0.41 | 0.43 | 0.36 | 0.19 | 1.48 | 1.48 |
| Public | 3.37 | 3.3 | 3.46 | 3.46 | 3.46 | 3.5 | 3.6 | 3.8 | 38.99 | 39.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11.07 | 11.08 | 11.17 | 11.46 | 11.46 | 11.46 | 11.46 | 11.46 | 115.95 | 116.45 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -6% | +13% | +22% | +18% |
| Operating Profit CAGR | -8% | +25% | +33% | +22% |
| PAT CAGR | -10% | +24% | +51% | +22% |
| Share Price CAGR | +56% | +8% | +35% | +31% |
| ROE Average | +19% | +26% | +25% | +22% |
| ROCE Average | +24% | +34% | +32% | +29% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.03 | 65.03 | 64.46 | 62.88 | 62.86 | 62.88 | 62.88 | 62.88 | 62.57 | 62.3 |
| FII | 0.81 | 1.45 | 0.93 | 3.28 | 3.36 | 2.84 | 2.51 | 2.34 | 2.52 | 2.92 |
| DII | 3.69 | 3.7 | 3.68 | 3.63 | 3.61 | 3.71 | 3.17 | 1.63 | 1.28 | 1.27 |
| Public | 34.97 | 34.97 | 35.54 | 37.12 | 37.14 | 37.12 | 37.12 | 37.12 | 37.43 | 37.7 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 72.55 | 72.55 |
| FII | 0.09 | 0.16 | 0.1 | 0.38 | 0.38 | 0.32 | 0.29 | 0.27 | 2.93 | 3.4 |
| DII | 0.41 | 0.41 | 0.41 | 0.42 | 0.41 | 0.43 | 0.36 | 0.19 | 1.48 | 1.48 |
| Public | 3.87 | 3.87 | 3.97 | 4.25 | 4.26 | 4.25 | 4.25 | 4.25 | 43.4 | 43.9 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11.07 | 11.08 | 11.17 | 11.46 | 11.46 | 11.46 | 11.46 | 11.46 | 115.95 | 116.45 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.